Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Novo Nordisk A/S
Novo Nordisk A/S News
Novo Nordisk A/S Quantitative Score
About Novo Nordisk A/S
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Novo Nordisk A/S Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Novo Nordisk A/S Financials
Table Compare
Compare NVO metrics with: | |||
|---|---|---|---|
Earnings & Growth | NVO | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | NVO | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | NVO | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | NVO | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Novo Nordisk A/S Income
Novo Nordisk A/S Balance Sheet
Novo Nordisk A/S Cash Flow
Novo Nordisk A/S Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Novo Nordisk A/S Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 2.2564 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-08-26 | 0.41155 | Quarterly |
| 2025-04-08 | 0.81907 | Quarterly |
| 2024-08-26 | 0.36234 | Quarterly |
| 2024-04-02 | 0.66342 | Quarterly |
| 2023-08-29 | 0.87634 | Quarterly |
Historical Market Cap
Shares Outstanding
Novo Nordisk A/S Executives
| Name | Role |
|---|---|
| Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board |
| Henrik Ehlers Wulff | Executive VP of CMC & Product Supply and Member of the Management Board |
| Martin Holst Lange | EVP of R&D, Chief Scientific Officer and Member of the Management Board |
| David S. Moore | Executive VP of US Operations & Member of Management Board |
| Emil Kongshøj Larsen | EVP of International Operations & Member of Management Board |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board | Male | 1971 | 2.7M |
| Henrik Ehlers Wulff | Executive VP of CMC & Product Supply and Member of the Management Board | Male | 1970 | 2.03M |
| Martin Holst Lange | EVP of R&D, Chief Scientific Officer and Member of the Management Board | 1970 | 1.92M | |
| David S. Moore | Executive VP of US Operations & Member of Management Board | Male | 1974 | -- |
| Emil Kongshøj Larsen | EVP of International Operations & Member of Management Board | Male | 1975 | -- |